China's healthcare industry is experiencing an unparalleled expansion, and it has become the second-largest sector in the world. This growth is attributed to various factors, such as a longer life expectancy, an aging population, and higher expectations for a better quality of life.

Moreover, the integration of cutting-edge technologies into the medical field, improved protection of intellectual property rights, and a long-term national health strategy - the Healthy China 2030 project - have created an almost perfect environment for the next major advancement in the healthcare industry.

The 14th Five-Year Plan, which charts China's development course for the next five years, includes a number of healthcare-related policy focuses, from optimizing balanced quality medical resources and promoting tiered diagnosis systems to the development of high-end medical devices and the proliferation of remote medical care.

China's newest catalog of industries for attracting foreign investment, which took effect on Jan 1, 2023, continues to encourage foreign investment in sectors including rare disease drugs, children's medicines and high-end medical devices.

According to the data analysis of China Business Industry Research Institute, the market size of China’s health industry reached 1.14 trillion yuan ($162.9 billion) in 2021, and it is expected to reach 1.27 trillion yuan ($181.4 billion) in 2022.

Consumer-oriented medical services maintain rapid growth. Apart from aesthetic medicine, oral, ophthalmology, mental health and so on become a continuous popular in the industry. The young consumer group in the health field is rapidly expanding. Compared with those born in the 1970s and 1980s, the current younger generation, known as Generation Z, is more keen on health preservation. Since the outbreak of the pandemic, the demand for internet medical services has also continued to increase, and the upgrading of digital healthcare will become one of the investment hotspots.